Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Third party research

OssDsign: Operational development in the right direction - ABG

OssDsign

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
59% y-o-y sales growth for Catalyst in Q1'25e
Lower our EBIT forecasts by 12-23% for '25e-'27e
Q1'25 results due 6 May


Q1'25 expectations

We expect OssDsign to continue to improve its market access by driving growth through new hospitals and more surgeons using the product. All in all, we forecast Q1 sales of SEK 43m, which corresponds to growth of 59% y-o-y, and +4% q-o-q compared to Q4'24. While sales can be lumpy between quarters, we forecast a positive sales trend on a trailing 12-month basis in the coming years. For Q1, we continue to expect opex to be at a fairly similar levels as in Q4'24, and we pencil in SEK 51m (vs. SEK 50m in Q4'24). On earnings, we forecast EBIT of SEK -17m in Q1'25e, driven by a gross margin of 95%. For the quarter we also include an NRI of SEK 7m related to the incentive programme.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.